- DeltaSleep has reported full commercial availability of its Notte Series CPAP, APAP and BiPAP devices, making it the only manufacturer producing clinical-grade sleep therapy devices in Canada.
- The Health Canada-licensed Notte Series is designed, assembled and serviced in Woodbridge, Ontario. DeltaSleep holds MDSAP certification and ISO 13485:2016 accreditation, with devices operating at 26 dB or below.
- Devices connect via Wi-Fi or 4G to DeltaSleep’s Canadian-hosted cloud, giving clinicians real-time therapy data while keeping patient information within Canadian infrastructure. Patients can generate compliance reports via QR code.
- Local manufacturing aims to reduce reliance on overseas supply chains, following shortages exposed by a 2021 international recall. DeltaSleep is now expanding distribution through Canadian home healthcare and sleep medicine providers.
Takeaways:
DeltaSleep’s Notte Series gives Canadian clinics and patients a locally made, Health Canada–licensed CPAP/APAP/BiPAP option that runs very quietly (≤26 dB) and sends therapy data to a Canadian‑hosted cloud, so clinicians can monitor treatment in real time while keeping patient information inside Canada. By assembling and servicing devices in Ontario and offering QR‑code compliance reports, DeltaSleep aims to reduce dependence on overseas supply chains (highlighted by the 2021 recall) and speed up support, which could make it easier for home‑care providers and sleep clinics to maintain steady device availability and service.
Source: CA Newswire
